Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Elixxer Ltd. V.QBA


Primary Symbol: V.ELXR

Healthcare Drug Manufacturers - Major
Elixxer Ltd is a Canada based company engaged in growing and producing medical-grade cannabis. It focuses on making investments in Nutraceuticals, Cosmetics, Pharma, and Cultivation and Extraction sectors.


TSXV:ELXR - Post by User

Elixxer Ltd. > Clarification 14.21%-14.99% ? a typo?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by Spardeion Oct 05, 2018 9:56am
107 Views
Post# 28751255

Clarification 14.21%-14.99% ? a typo?

Clarification 14.21%-14.99% ? a typo?MONTREAL, Oct. 5, 2018 /CNW Telbec/ - LGC Capital Ltd. (TSXV: LG) ("LGC") is pleased to advise that Australian medical cannabis company Little Green Pharma (LGP) in which LGC has a 14.21% interest, 

MONTREAL, April 27, 2018 /CNW Telbec/ - LGC Capital Ltd. (TSXV: LG) ("LGC") is pleased to announce it has been advised by Australian Medical Cannabis LP, Little Green Pharma, that it has completed its first Australian harvest this week. LGC recently increased its strategic interest in Little Green Pharma to 14.99%
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities